New regulatory changes in pharma and healthcare: Q1 2025 Legal Overview
The beginning of 2025 brought updates to legislation affecting the pharmaceutical and healthcare sectors in Belarus and across the EAEU. REVERA Belarus team has compiled a comprehensive Q1 2025 Legal Overview, highlighting the most critical regulatory changes businesses need to know.
Among the topics covered:
- New EAEU rules for drug and biological product registration;
- Updated requirements for patient information leaflets;
- Changes in laboratory and diagnostic service regulation;
- Restrictions on iron supplement advertising;
- Concepts for unified markets of medicines and medical devices.